Answers are grounded in this paper and cite their sources.
This retrospective cohort study investigated antigen-specific antibody responses to SARS-CoV-2 and serum inflammatory markers in coronavirus disease 2019 (COVID-19) patients of varying severity. Serum or plasma samples collected early in the pandemic were analyzed for the presence of IgG antibodies and IgG subclasses targeting the recombinant spike (S) and nucleocapsid (N) proteins of SARS-CoV-2. Correlation analyses were conducted to assess the possible relationship between IgG subclasses to SARS-CoV-2 proteins and severity of the disease.It was shown that IgG levels against S- and N-proteins decreased in the most severe COVID-19 cases, potentially attributed to delayed IgG formation compared to milder infections. The presence of anti-N IgG at the time of hospitalization correlated with subsequent recovery. At the same time, anti-N IgG1 and IgG3 correlated with the detection of the viral RNA in the blood. With a mild course of infection, anti-spike IgG1 titers negatively correlated with such markers as CRP, fibrinogen and NLR levels. The highest levels of anti-spike IgG observed in moderate COVID-19 cases exhibited a positive correlation with serum histamine levels.
No takes yet. Share an insight, caveat, or question.
Desheva et al. (2023) studied this question.